delta 24-sterol reductase: Clinical Trials

9 trials of delta 24-sterol reductase, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

4 completed, 2 recruiting, 2 unknown, 1 terminated. 4 Not applicable, 1 Phase 2, 1 Phase 3.

By phase and status

PhaseTrialsStatus
Not applicable4Recruiting 2, Completed 1, Terminated 1
Phase 21Unknown 1
Phase 31Unknown 1

Follow delta 24-sterol reductase: new trials by email Literature Review of delta 24-sterol reductase trials Research Report on delta 24-sterol reductase

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Testing Warning Labels for Retail Cannabis Products Using a Discrete Choice Experiment
Discrete choice experiment (DCE) survey-experiment - Cannabis Use, Risk Perception
Not applicableRecruitingUniversity of Oklahoma4502026-05-192026-07-27
A Space-expanding Shield in Decompressive Hemicraniectomy for Stroke
DCE + SPACE SHIELD, DCE + CP - Stroke
Not applicableRecruitingInsel Gruppe AG, University Hospital Bern1102025-06-012025-07-09
To Better Understand the Most Important Factors for Patients When They Decide on the Type of Treatment They Receive for Muscle Invasive Bladder Cancer (MIBC).
Discrete Choice Experiment (DCE) Patients DCE Questionnaire, Semi-Structured Interview Patients Interview - Muscle Invasive Bladder Cancer, Surgery
UnknownKing's College London602022-07-202023-03-08
Metastatic Prostate Cancer Men's Attitudes Towards Treatment of the Local Tumour and Metastasis Evaluative Research
Semi-Structured Interview Healthcare Professional, Semi-Structured Interview Patients, Think Aloud Interview Patients - Prostate Cancer Metastatic, Radiotherapy Side Effect
CompletedImperial College London3202020-12-032023-02-08
Real-time Ultrasound Imaging as Feedback for Deep Cervical Extensors Activation
DCE without RUSI feedback, DCE + RUSI feedback about performance - Neck Disorder
Phase 2 / Phase 3UnknownUniversity of Valencia302019-12-052019-12-17
Quantitative Imaging Biomarkers for Sarcoma
DCE and DWI MRI, Surgery - Sarcoma
Not applicableCompletedColumbia University322015-10-012019-03-26
Predictive MRI Metrics for Tumor Aggressiveness in Papillary Thyroid Cancer
diffusion weighted (DW) MRI, dynamic contrast agent (DCE) MRI - Papillary Thyroid Cancer
CompletedMemorial Sloan Kettering Cancer Center1232014-06-242021-12-08
Quantitative Imaging Biomarkers of Treatment Response in Osteosarcoma and Ewing Sarcoma
DCE-MRI, DW-MRI, MT-MRI, and CEST-MRI - Osteosarcoma, Paget's Disease
Not applicableTerminatedVanderbilt-Ingram Cancer Center62013-03-012017-05-08
Quantitative Dynamic Contrast Enhanced Breast MRI
perform dynamic contrast enhanced (DCE) MRI - Breast Cancer
CompletedMemorial Sloan Kettering Cancer Center1162005-09-012015-07-08

Conditions studied

Patient Satisfaction (2)  ·  Bone Neoplasms (1)  ·  Breast Neoplasms (1)  ·  Neoplasms (1)  ·  Osteitis Deformans (1)  ·  Osteosarcoma (1)  ·  Patient Acceptance of Health Care (1)  ·  Patient Preference (1)  ·  Radiation Injuries (1)  ·  Sarcoma (1)  ·  Sarcoma, Ewing (1)  ·  Stroke (1)  ·  Thyroid Cancer, Papillary (1)  ·  Urologic Neoplasms (1)

Sponsors

Memorial Sloan Kettering Cancer Center (2)  ·  Columbia University (1)  ·  Imperial College London (1)  ·  Insel Gruppe AG, University Hospital Bern (1)  ·  King's College London (1)  ·  University of Oklahoma (1)  ·  University of Valencia (1)  ·  Vanderbilt-Ingram Cancer Center (1)

Countries

United States (5)  ·  United Kingdom (2)  ·  Spain (1)  ·  Switzerland (1)

Top investigators

Amita Dave, PhD (1)  ·  Hashim Ahmed, PhD, FRCS (1)  ·  Lawrence H Schwartz, MD (1)  ·  Schucht Philippe, MD (1)  ·  Simon Hughes (1)  ·  Sunitha Thakur, PhD (1)  ·  Vicki Keedy, MD (1)  ·  Zachary Massey, PhD (1)

Results publications

PMID 34794989

NIH funding

K01DA057395 (1), U01CA142565 (1), U54CA168512 (1)